간행물

생화학분자생물학회입니다.


EMM

Protein lactylation in cancer: mechanisms and potential therapeutic implications

  • 작성자

    Hyunsoo Rho
  • 작성일자

    2025-07-15
  • 조회수

    903
Hyunsoo Rho ( hrho@ewha.ac.kr )
2025-presentAssistant Professor, College of Pharmacy, Ewha Womans University, South Korea
2023-2025Research Assistant Professor, School of Pharmacy, Jeonbuk National University, South Korea
2016-2023Ph.D., College of Medicine, Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, USA
2012-2014M.S., College of Pharmcy, Seoul National University, South Korea

Protein lactylation in cancer: mechanisms and potential therapeutic implications

Increased glycolysis, which leads to high lactate production, is a common feature of cancer cells. Recent evidence suggests that lactate plays a role in the post-translational modification of histone and nonhistone proteins via lactylation. In contrast to genetic mutations, lactylation in cancer cells is reversible. Thus, reversing lactylation can be exploited as a pharmacological intervention for various cancers. Here we discuss recent advances in histone and nonhistone lactylation in cancer, including l-, d- and s-lactylation, as well as alanyl-tRNA synthetase as a novel lactyltransferase. We also discuss potential approaches for targeting lactylation as a therapeutic opportunity in cancer treatment.

Exp Mol Med 57, 545–553 (2025). https://doi.org/10.1038/s12276-025-01410-7
https://pubmed.ncbi.nlm.nih.gov/40128358/